The effect of coenzyme Q10 on idiopathic chronic dilated cardiomyopathy in children

Pediatric Cardiology

Volumn 26, Issue 4, 2005, Pages 361-366

  Soongswang, J ^a   Sangtawesin, C ^b   Durongpisitkul, K ^a   Laohaprasitiporn, D ^a   Nana, A ^a   Punlee, K ^a   Kangkagate, C ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b QUEEN SIRIKIT NATIONAL INSTITUTE OF CHILD HEALTH   (Thailand)

Author keywords

Chronic congestive heart failure; Coenzyme Q10; Dilated cardiomyopathy

Indexed keywords

CARDIAC AGENT; UBIDECARENONE;

ADD ON THERAPY; ARTICLE; CARDIOGENIC SHOCK; CHILDHOOD DISEASE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; ELECTROCARDIOGRAM; ENZYME ACTIVITY; ENZYME MECHANISM; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE EJECTION TIME; HUMAN; IDIOPATHIC DISEASE; MALE; PRESCHOOL CHILD; PROSPECTIVE STUDY; QRS COMPLEX; QUALITY OF LIFE; STATISTICAL SIGNIFICANCE; SUPPLEMENTATION; SYMPTOMATOLOGY; THORAX RADIOGRAPHY;

ADOLESCENT; ANTIOXIDANTS; CARDIOMYOPATHY, DILATED; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CYTOPROTECTION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; STROKE VOLUME; TREATMENT OUTCOME; UBIQUINONE;

EID: 27744608152     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-004-0742-1     Document Type: Article

References (24)

1. A Arola J Tuominen O Ruuskanen E Jokinen 1998 Idiopathic dilated cardiomyopathy in children: prognostic indicators and outcome Prog Childhood Dilated Cardiomyopathy 101 369 376
2. E Baggio R Gandini AC Plancher M Passeri G Carmosino 1993 Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure (interim analysis) Clin Invest 71 S145 S149
3. MR Bristow EM Gilbert WT Abraham 1996 Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure Circulation 94 2807 2816
4. C Canter D Naftel R Caldmell 1997 Survival and risk factors for death after cardiac transplantation in infants. A multi-institute study Circulation 96 227 231
5. D Connolly M Rutkowski M Auslender M Artman 2001 The New York University Pediatric Heart Failure Index. A new method of quantifying chronic heart failure severity in children J Pediatr 138 644 648
6. V Fuster BJ Gersh ER Giuliani 1981 The natural history of idiopathic dilated cardiomyopathy Am J Cardiol 47 525 531
7. RD Greenwood AS Nadas DC Fyler 1976 The clinical course of primary myocardial disease in infants and children Am Heart J 92 549 560
8. RA Johnson I Palacios 1982 Dilated cardiomyopathies of the adult N Engl J Med 307 1051 1058
9. A Khan AB Gazzaniga 1996 Mechanical circulatory assistance in pediatric patients with cardiac failure Cardiovasc Surg 4 43 49
10. PH Langsjoen PH Langsjoen K Folkers 1990 Long-term efficacy and safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy Am J Cardiol 65 521 523
11. G Lenaz 1988 The role of mobility of redox components in the inner mitochondrial membrane J Membr Biol 104 193 209
12. G Lenaz C Castelluccio M Cavazzoni H Rauchova GP Castelli 1991 Coenzyme Q saturation kinetics of mitochondrial enzymes: theory, experimental aspects and biomedical implications K Folkers T Yamagami GP Littarru Biomedical and Clinical Aspects of Coenzyme Q Elsevier Amsterdam 11 18
13. AB Lewis M Chabot 1991 Outcome of infants and children with dilated cardiomyopathy Am J Cardiol 68 365 369
14. TA Manolio KL Baughman R Rodenhelfer 1992 Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart Chest Lung and Blood Institute workshop) Am J Cardiol 69 1458 1466
15. A Morisco A Nappi L Argenziano 1994 Noninvasive evaluation of cardiac hemodynamics during exercise in patients with chronic heart failure: effects of short-term coenzyme Q10 treatment Mol Aspects Med 15 S155 S163
16. C Morisco B Trimarco M Condorelli 1993 Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study Clin Invest 71 S134 S136
17. AS Mortensen S Vashanacikit K Muratsu 1990 Coenzyme Q10: clinical benefit with biochemical correlates suggesting a scientific breakthrough in the management of chronic heart failure Int J Tissue React 12 155 162
18. R Pires L Elvas P Mantciro 2001 Biventricular pacing early experience Rev Port Cardiol 20 1235 1239
19. F Rengo P Abete P Kandino 1993 Role of metabolic therapy in cardiovascular disease Clin Invest 71 S124 S128
20. A Sinha K Filzmaier O Breithardt 2002 Usefulness of brain natriuretic peptide release as a surrogate marker of the efficacy of long-term cardiac resynchronization therapy in patients with heart failure Am J Cardiol 91 755 758
21. AM Soja SA Mortensen 1997 Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analysis of clinical trails Mol Aspects Med 18 S159 S168
22. J Soongswang K Durongpisitkul S Ratanarapee 2002 Cardiac troponin T: its role in the diagnosis of clinically suspected myocarditis and dilated cardiomyopathy in children Pediatr Cardiol 23 531 535
23. H Suma T Isomura T Horii 1998 Two-year expressive of the Batista operation for nonischaemic cardiomyopathy J Cardiol 32 269 276
24. K Swedberg C Hoffman-Bang N Rehnqvist 1995 Coenzyme Q10: an adjunction in treatment of congestive heart failure J Cardiac Failure 1 101 107